Guangzhou Baiyunshan Pharmaceutical Holdings (SHA:600332, HKG:0874) subsidiary Guangzhou Pharmaceutical is looking to issue 1.6 billion yuan in medium-term securities and ultra-short term financing bills for up to 2 billion yuan, according to a Saturday filing with the Shanghai bourse.
Both issuances are valid for two years, the filing said.
China Merchants Bank (HKG:3968, SHA:600036) and Industrial Bank (SHA:601166) are the joint underwriters of the issuance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.